Overseas Regulatory Announcement-Announcement on Escitalopram Oxalate Tablets(10mg) Having Obtained the Drug Registration Certificate

Monthly Return of Equity Issuer on Movements in Securities for the month ended 3

Proposed Amendments to the Articles of Association

Announcement Notice of Board Meeting

Overseas Regulatory Announcement-Announcement on Cefaclor Capsules of Wholly-own

Overseas Regulatory Announcement-Announcement on Peramivir Injection Having Obtained the Notification of Approval of Supplementary Drug Application

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Final Dividend for the Year Ended 31 December 2023

Proposed Amendments to the Articles of Association

Proposed Change of Auditors